Invesco Health Care Fund Class A (GGHCX)
Fund Assets | 1.34B |
Expense Ratio | 1.06% |
Min. Investment | $1,000 |
Turnover | n/a |
Dividend (ttm) | 1.84 |
Dividend Yield | 4.80% |
Dividend Growth | n/a |
Payout Frequency | n/a |
Ex-Dividend Date | Dec 16, 2024 |
Previous Close | 35.36 |
YTD Return | 1.10% |
1-Year Return | -1.38% |
5-Year Return | 26.54% |
52-Week Low | n/a |
52-Week High | n/a |
Beta (5Y) | 0.76 |
Holdings | 82 |
Inception Date | Aug 7, 1989 |
About GGHCX
The Fund's investment strategy focuses on GL Health/Biotech with 1.06% total expense ratio. The minimum amount to invest in AIM Investment Funds (Invesco Investment Funds): Invesco Health Care Fund; Class A Shares is $1,000 on a standard taxable account. AIM Investment Funds (Invesco Investment Funds): Invesco Health Care Fund; Class A Shares seeks long-term growth of capital. GGHCX invests, under normal circumstances, at least 80% of its net assets in securities of issuers engaged primarily in health care-related industries, and in derivatives and other instruments that have economic characteristics similar to such securities.
Performance
GGHCX had a total return of -1.38% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.79%.
Top 10 Holdings
51.20% of assetsName | Symbol | Weight |
---|---|---|
Eli Lilly and Company | LLY | 9.88% |
Boston Scientific Corporation | BSX | 8.83% |
Intuitive Surgical, Inc. | ISRG | 5.74% |
UnitedHealth Group Incorporated | UNH | 5.53% |
Stryker Corporation | SYK | 4.54% |
AbbVie Inc. | ABBV | 4.09% |
Vertex Pharmaceuticals Incorporated | VRTX | 3.95% |
Cencora, Inc. | COR | 3.61% |
Abbott Laboratories | ABT | 2.81% |
argenx SE | ARGX | 2.22% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 16, 2024 | $1.8353 | Dec 16, 2024 |
Dec 16, 2021 | $9.9297 | Dec 16, 2021 |
Dec 15, 2020 | $0.4737 | Dec 15, 2020 |
Dec 13, 2019 | $1.4728 | Dec 13, 2019 |
Dec 14, 2018 | $2.9024 | Dec 14, 2018 |
Dec 13, 2017 | $2.4481 | Dec 13, 2017 |